The View of Turkish Oncologists Regarding MSI Status and Tumor Localization in Stage II and III Colon Cancer

被引：0
|
作者：
Ismail Beypinar
Hacer Demir
Murat Araz
Meltem Baykara
Nuri Faruk Aykan
机构：
[1] Afyon Health Sciences University School of Medicine,Department of Internal Medicine and Medical Oncology
[2] Necmettin Erbakan University School of Medicine,Department of Internal Medicine and Medical Oncology
[3] İstinye University,Department of Medical Oncology
来源：
Journal of Gastrointestinal Cancer | 2022年 / 53卷
关键词：
Colon cancer; Adjuvant treatment; Microsatellite instability; Duration of treatment; MSI testing;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：57 / 63
页数：6
相关论文
共 50 条
  • [1] The View of Turkish Oncologists Regarding MSI Status and Tumor Localization in Stage II and III Colon Cancer
    Beypinar, Ismail
    Demir, Hacer
    Araz, Murat
    Baykara, Meltem
    Aykan, Nuri Faruk
    JOURNAL OF GASTROINTESTINAL CANCER, 2022, 53 (01) : 57 - 63
  • [2] Prognostic significance of primary tumor localization in stage II and III colon cancer
    Sakin, Abdullah
    Arici, Serdar
    Secmeler, Saban
    Can, Orcun
    Geredeli, Caglayan
    Yasar, Nurgul
    Demir, Cumhur
    Demir, Osman Gokhan
    Cihan, Sener
    WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY, 2018, 10 (11) : 410 - 420
  • [3] Adjuvant therapy report card: Patients with stage II/III colon cancer grade their oncologists
    Love, N.
    Ziel, K. Ault
    Bylund, C.
    Elder, M.
    Ellis, L. M.
    Grothey, A.
    Meropol, N. J.
    Paley, D.
    Ravdin, P. M.
    Saltz, L. B.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [4] MSI plus STAGE II/III COLON CANCER PATIENTS BENEFIT FROM CAPECITABINE ADJUVANT MONOTHERAPY
    Dimovski, Aleksandar
    Matevska, Nadica
    Eftimov, Aleksandar
    Nestorovska, Aleksandra Kapedanovska
    Petrusevska, Natalija Angelovska
    Angelovska, Biljana
    Jashar, Djingis
    Mitrevski, Nikola
    Josifovski, Toni
    ANNALS OF ONCOLOGY, 2012, 23 : 106 - 106
  • [5] Impact of Tumor Side on Clinical Outcomes in Stage II and III Colon Cancer With Known Microsatellite Instability Status
    Akce, Mehmet
    Zakka, Katerina
    Jiang, Renjian
    Williamson, Shayla
    Alese, Olatunji B.
    Shaib, Walid L.
    Wu, Christina
    Behera, Madhusmita
    El-Rayes, Bassel F.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [6] Status of Active Specific Immunotherapy for Stage II, Stage III, and Resected Stage IV Colon Cancer
    Deschoolmeester, Vanessa
    Smits, Evelien
    Peeters, Marc
    Vermorken, Jan B.
    CURRENT COLORECTAL CANCER REPORTS, 2013, 9 (04) : 380 - 390
  • [7] Prognostic and predictive significance of MSI in stages II/III colon cancer
    Saridaki, Zacharenia
    Souglakos, John
    Georgoulias, Vassilis
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (22) : 6809 - 6814
  • [8] Prognostic effect of tumor location in stage II and III colon cancer.
    Ozveren, Ahmet
    Surmeli, Zeki Gokhan
    Turgut, Asli
    Karaca, Burcak
    Karabulut, Bulent
    Sanli, Ulus Ali
    Uslu, Ruchan
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [9] Thymidylate synthase haplotype is associated with tumor recurrence in stage II and stage III colon cancer
    Lurje, Georg
    Zhang, Wu
    Yang, Dongyun
    Groshen, Susan
    Hendifar, Andrew E.
    Husain, Hatim
    Nagashima, Fumio
    Chang, Heung M.
    Fazzone, William
    Ladner, Robert D.
    Pohl, Alexandra
    Ning, Yan
    Iqbal, Syma
    El-Khoueiry, Anthony
    Lenz, Heinz-Josef
    PHARMACOGENETICS AND GENOMICS, 2008, 18 (02): : 161 - 168
  • [10] Stage II Colon Cancer: Importance of primary Tumor Localization and Mismatch Repair Status as Lead Parameters for adjuvant Therapy
    Moeslein, G.
    COLOPROCTOLOGY, 2018, 40 (05) : 379 - 382
12345